About the Division of Therapeutic Immunology and Transfusion Medicine

Michael obtained his Ph.D. from Karolinska Institutet 2006. 2012 he reached the level of associate professor in Immunology. Michael is employed by the Karolinska University Hospital where he is responsible for the section of Clinical Immunology at the department of Clinical Immunology and Transfusion medicine. Together with his research group he focus on T-cell Immunology and Immune Therapy.

Lisa-Mari received her Ph.D. from Karolinska Institutet in 2010 with a project investigating cholesterol and bile acid metabolism in hepatocytes. After that she worked as a post doc and later on as a lab manager at the Liver Cell Lab, CLINTEC, with the main focus to use primary hepatocytes for cell transplantation in patients with metabolic diseases. She joined Michael Uhlin’ s group in 2017 and is working as a senior lab manager.

Lucas received his Pharm.D. from Ouro Preto Pharmacy School, Brazil, in 2011. His Ph.D. was obtained from University of São Paulo, Brazil, in 2017, where he worked with autologous hematopoietic stem cell transplantation to treat autoimmune disease patients. He joined Dr Uhlin´s lab in 2017 and has been working in the development and characterization of bispecific antibodies, specially T-cell and NK-cell engagers (BITE/BIKE), to treat leukemia (AML and MDS) patients.

Eoghan received his Master’s degree in Molecular Cell Biology from University College Cork, Ireland in 2018. His Ph.D in Molecular Biology and Genetics was obtained at Aarhus University, Denmark in 2022. During his Ph.D Eoghan’s research focused on exploring the biogenesis of a subset of RNAs characterised by their closed circular structure, known as circular RNAs. Eoghan’s research focused on investigating the contribution of RNA binding proteins in regulating circular RNA production. Eoghan joined Professor Michael Uhlin’s lab in 2022 in collaboration with the Norwegian Biotech company Targovax.

Ahmed has graduated from faculty of Medicine in 2007, and obtained a Master degree in Medical Biochemistry and Molecular Biology from Egypt in 2013.  He started his doctoral program at Karolinska Institutet in 2015. The main aim of his project is to study γδ T cell reconstitution after allogeneic HSCT, and to understand how different transplant related factors affect it. In addition, he is also interested in studying the development and functionality of γδ T cells in detail after HSCT and their correlation to clinical outcome.

Linda has a Master’s degree in biochemistry and a Bachelor’s degree in sports medicine from Umeå University 2006, with complementary courses in immunology and transfusion medicine. Linda is a Technical Manager at the department of Clinical Immunology and Transfusion Medicine at Karolinska University Hospital, where she has specialized in blood component production since 2009. In 2017, she started her PhD degree education for Michael Uhlin. She focuses on red blood cell storage lesion during development of new production strategies for red blood cell components.

Faisal received his bachelor’s degree in Biochemistry in 2008 from King Saud University. In 2016, he completed his MSc degree of Science in Cell Biology, Genetics, and Histology at King Saud University with a study investigating the effect of extracts derived from Rhazya stricta species on human stem cell proliferation and differentiation. He joined Michael Uhlin’ s group as PhD student in 2020. His projects aim to in-depth characterize both phenotypic and functional changes of γδ T cells after hematopoietic stem cell transplantation (HSCT). He will also identify and explore the rare subsets of γδ T cells in transplant patients in long-term aspect using single cell isolation and sequencing technology.

Emelie is a biomedical scientist (BMA) and received her Master’s degree in biomedical laboratory science in 2014 from Karolinska Institutet after having done her bachelor and master thesis work under the supervision of Michael Uhlin with focus on immune reconstitution after allogeneic stem cell transplantation. She is currently a PhD student in the group and her research focuses on co-stimulation and co-inhibition of tumor-infiltrating lymphocytes in human solid tumors. She primarily works with primary cells from human ovarian cancer and this work aims to increase knowledge of the presence, phenotype and functionality of infiltrating T-cells and T-cell subsets, and ultimately ways to enhance the responsiveness of these cells.